WHO demand mass production of new COVID-19 drug

By
Bgluck
-
0
BEIJING, March 2, 2020 -- Chinese President Xi Jinping, also general secretary of the Communist Party of China Central Committee and chairman of the Central Military Commission, learns about the progress on the vaccine and anti-body during his visit to the Academy of Military Medical Sciences in Beijing, capital of China, March 2, 2020. Xi on Monday inspected the scientific research on novel coronavirus disease COVID-19 as well as the diagnosis and treatment of the disease in his visit to two institutes in Beijing. (photo by Ding Haitao/Xinhua via Getty)
Spread the post

On Monday the World Health Organization (WHO) has called for an increase in production of dexamethasone.

Dexamethasone is a cheap steroid, so far the drug has shown to reduce deaths in critically ill COVID-19 patients.

Tedros Adhanom Ghebreyesus, WHO chief, told a virtual news conference that demand had already increased, after a British trial of the drug became public.

<img class="i-amphtml-intrinsic-sizer" role="presentation" src="data:;base64,” alt=”” aria-hidden=”true” />

About 2,000 patients were administered the drug by Oxford University researchers and it reduced deaths by 35 percent among the most sickly.

“Although the data are still preliminary, the recent finding that the steroid dexamethasone has life-saving potential for critically ill COVID-19 patients gave us a much-needed reason to celebrate,” Tedros said.

“The next challenge is to increase production and rapidly and equitably distribute dexamethasone worldwide, focusing on where it is needed most,” he added.


Spread the post

RELATED ARTICLESMORE FROM AUTHOR

LEAVE A REPLY

Please enter your comment!
Please enter your name here